Unum Therapeutics is a biopharmaceutical company focused on developing curative cell therapies for solid tumors. Co.'s proprietary technology includes its Bolt-On Chimeric Receptor platform, designed to discover bolt-on transgenes to improve the functionality of engineered T cells and overcome resistance of the solid tumor microenvironment to T cell attack. Co. has also developed product candidates using its proprietary technology, Antibody-Coupled T cell Receptor, an autologous engineered T-cell investigational therapy that is designed to combine the cell-killing ability of T cells and the tumor-targeting ability of co-administered antibodies to exert antitumor immune responses. We show 12 historical shares outstanding datapoints in our UMRX shares outstanding history coverage, used to compute UMRX market cap on those dates.
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing UMRX market cap history over the course of time is important for investors
interested in comparing UMRX's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of UMRX versus a peer is one thing; comparing
UMRX market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like UMRX can fluctuate over the course of history.
With this page we aim to empower investors researching UMRX by allowing them to research the UMRX market cap history. |
Free UMRX Email Alerts:
Video: The Importance of Market Cap
